Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes

Diabetes

Volumn 41, Issue 1, 1992, Pages 53-61

  Santamaria, Pere ^a   Nakhleh, Raouf E ^a   Sutherland, David E ^a   Barbosa, Jose J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3;

ADULT; ARTICLE; CASE REPORT; CELL CULTURE; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULITIS; PANCREAS TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TOPICAL DRUG ADMINISTRATION;

ADULT; ANTIGENS, CD; CASE REPORT; CELLS, CULTURED; CYTOMEGALOVIRUS; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; HISTOCOMPATIBILITY TESTING; HUMAN; INTERLEUKIN-2; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PANCREATIC DISEASES; RECURRENCE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYROID GLAND; TRANSPLANTATION, HOMOLOGOUS;

EID: 0026565852     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.41.1.53     Document Type: Article

References (38)

1. Santamaria P, Barbosa J: Immunogenetics of type I diabetes. In Immunogenetics of Autoimmune Disease. Farid NR, Ed. Boca Raton, FL, CRC, 1991, p. 180-98
2. Bottazzo GF, Dean BM, McNally JM, McKay EH, Swift PGF, Gamble DR: In situ characterization of autoimmune phenomenon: an expression of HLA molecules in the pancreas of diabetic insulinitis. N Engl J Med 313:353-60, 1985
3. + T cells. J Exp Med 166:823-32, 1987
4. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140:52-58, 1988
5. Nagata M, Yokono K, Hayakawa M, Kawase Y, Hatamori N, Ogawa W, Yonezawa K, Shii K, Baba S: Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J Immunol 143:1155-62, 1984
6. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B: Pancreatic islet-specific T-cell clones from non-obese diabetic mice. Proc Natl Acad Sci USA 86:8000-8004, 1989
7. Reich EP, Sherwin RS, Kanagawa O, Janeway CA: An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature (Lond) 341:326-28, 1989
8. Padula SJ, Pollard MK, Lingenheld EG, Clark RB: Maintenance of antigen specificity by human interleukin 2 dependent T cell lines. J Clin Invest 75:788-97, 1985
9. Santamaria P, Bryan MK, Barbosa JJ: Long term expansion of cytomegalovirus-specific T cell lines in the absence of antigen or antigen-presenting cells: use of polystyrene particles coated with agnostic antibodies. J Immunol Meth 132:1-11, 1990
10. Londei M, Grubeck-Lobenstein B, deBernardinis P, Greenall C, Feldmann M: Efficient propagation and cloning of human T cells in the absence of antigen by means of OKT3, interleukin 2 and antigen-presenting cells. Scand J Immunol 27:35-43, 1988
11. Sibley RK, Sutherland DER, Goetz F, Michael AF: Recurrent diabetes mellitus in the pancreas iso- and allograft. Lab Invest 53:132-44, 1985
12. Sutherland DER, Goetz FC, Sibley RK: Recurrence of disease in pancreas transplants. Diabetes 38 (Suppl. 1):85-87, 1989
13. Nakhleh, RE, Snover DC, Weisdorf S, Platt JL: Immunopathology of graft-versus-host disease in the upper gastrointestinal tract. Transplantation 48:61-65, 1989
14. Gehrz RC, Fuad S, Liu YN, Bach FH: HLA class II restriction of T helper cell response to cytomegalovirus (CMV). I. Immunogenetic control of restriction. J Immunol 138:3145-51, 1987
15. Sibley RK: Pancreas transplantation. In The Pathology of Organ Transplantation. Sale GE, Ed. Boston, MA, Butterworths, 1990, p. 179-215
16. Sibley RK, Sutherland DER: Pancreas transplantation: an immunohistological and histopathologic examination of 100 grafts. Am J Pathol 128:151-70, 1987
17. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS: The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267-74, 1986
18. Elias D, Markovits D, Reshef T, van der Zee R, Cohen I: Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 87:1576-80
19. Boitard C, Yasunami R, Dardenne M, Bach JF: T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169:1669-80, 1989
20. Pankewycz O, Strom TB, Rubin-Kelley VE: Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes. Eur J Immunol 21:873-79, 1991
21. DeBernardinis P, James RFL, Wise PH, Londei M, Lake SP, Feldman M: Do CD4-positive cytotoxic T cells damage islet beta cells in type 1 diabetes? Lancet 2:823-24, 1988
22. Lanier LL, Ruitenberg J, Bolhuis RLH, Borst J, Phillips JH, Testi R: Structural and serological heterogeneity of γ,δ T cell antigen receptor expression in thymus and peripheral blood. Eur J Immunol 18:1985-92, 1988
23. Groh V, Porcelli S, Fabbi M, Lanier LL, Picker LJ, Anderson T, Wainke RA, Bhau AK, Strominger JL, Brenner MB: Human lymphocytes bearing the TcR γ,δ are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med 169:1277-94, 1989
24. Bank I, DePinho RA, Brenner MB, Cassimeris J, Alt FW, Chess LA: Functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature (Lond) 322:179-81, 1986
25. Janeway CA Jr, Jones B, Hayday AC: Specificity and function of T cells bearing γδ receptors. Immunol Today 6:73-76, 1988
26. + T cells respond to mycobacterial heat-shock protein. Nature (Lond) 340: 309-12, 1989
27. + T cells in the primary immune response to mycobacterium tuberculosis. Science 244:713-16, 1989
28. Jones DB, Hunter NR, Duff GW: Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes. Lancet 336:583-85, 1990
29. Raulet DH: Antigens for γδ cells. Nature (Lond) 339:342-43, 1989
30. Holoshitz J, Koning F, Coligan JE, De Bruyn J, Strober S: Isolation of CD4-CD8-mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature (Lond) 339:226-29, 1989
31. Meuer SC, Hussey ME, Cantrell DA, Hogdon JC, Schlossman SF, Smith KA, Reinhertz EL: Triggering of the T3-T, antigen receptor complex results in clonal T cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci USA 81: 1509-13, 1984
32. Clark EA, Ledbetter JA: Amplification of the immune response by agonistic antibodies. Immunol Today 7:267-269, 1986
33. Weber WEJ, Buurman WA, Vandermeeren MMPP, Raus JCM: Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells. J Immunol 135:2337-42; 1985
34. + cells via CD3: requirements for second signals. Scand J Immunol 26:197-205, 1987
35. Weetman AP, Volkman D, Burman KD, Margolik JB, Petrick P, Weintraub BD, Fauci AS: The production and characterization of thyroid-derived T cell lines in Graves' disease and Hashimoto's thyroiditis. Clin Immunol Immunopathol 39:139-50, 1986
36. Del Prete GF, Maggi E, Mariotti S, Tiri A, Vercelli A, Parronchi P, Macchia D, Pinchera A, Ricci M, Romagnani S: Cytolytic T lymphocytes with natural killer activity in thyroid infiltrate of patients with Hashimoto's thyroiditis: analysis at clonal level. J Clin Endocrinol Metab 62:52-57, 1985
37. Bagnasco M, Venuti D, Prigione I, Torre GC, Ferrini S, Canonica GW: Graves' disease: phenotypic and functional analysis at the clonal level of the T cell repertoire in peripheral blood and in thyroid. Clin Immunol Immunopathol 47:230-39, 1988
38. Margolik JB, Weetman AP, Burman KD: Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-gamma. Clin Immunol immunopathol 47:208-18, 1988